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Motoring to a signaling check-up
T
he Smad2 signaling protein is shut-
tled back to the membrane to check 
up on its receptor, according to 
Julie Batut, Michael Howell and Caroline 
Hill (Cancer Research UK, London). The 
check-ups ensure that intracellular signal-
ing accurately reﬂ  ects the activation status 
of the membrane-bound receptor.
Smad proteins are phosphorylated 
by and act downstream of TGF-β recep-
tors. Once Smad2 has helped activate 
transcription, the group previously found, 
it is shuttled out of the nucleus.
They now discover that this discarded Smad2 is dragged back to the 
TGF-β receptor by the microtubule motor kinesin. Smad2 phosphorylation 
and nuclear accumulation was prevented by microtubule poisons and an 
antikinesin drug, even in the presence of a constitutively activated receptor. 
This result held true in frog and zebraﬁ  sh embryos and mammalian cells. 
Unphosphorylated Smad2 coimmunoprecipitated with a kinesin light chain.
Long-range transport of Smad2 by kinesin has not yet been demon-
strated. Hill also hopes to ﬁ  nd a motor that transports active Smad2 from 
receptor to nucleus. Smad and STAT signaling pathways may be particularly suited to undertake such 
journeys, as in these two cases a single protein ﬁ  rst interacts at the membrane and then acts in the 
nucleus. In these cases, “I think diffusion is never enough,” says Hill. “With cells we tend to assume 
that things are swimming around in a soup, but I think everything is directed.”
Reference: Batut, J., et al. 2007. Dev. Cell. 12:261–274.
Chemokine blockade
A 
fetus must be sheltered from any 
infl  ammatory battle taking place in the 
mother. Now, Yeny Martinez de la 
Torre, Alberto Mantovani (University of Milan, 
Italy), and colleagues report that a decoy 
receptor in the placenta captures potentially 
dangerous pro-infl  ammatory chemokines from 
the mother. This scavenging suppresses 
infl  ammation and prevents fetal loss.
Decoy receptors such as the D6 receptor 
bind many infl  ammatory chemokines without 
activating intracellular signaling. Instead, the 
receptor and chemokine are internalized and the 
chemokine is destroyed.
The Italian group confi   rmed that D6 is 
expressed in the placenta, specifi   cally on the 
apical side of syncytial trophoblasts. This is the 
side looking at the maternal blood and thus “a 
strategic location at the very interface between 
mother and fetus,” says Mantovani.
To test the function of D6, the team injected 
pro-infl   ammatory LPS. The response was 
greater in mice lacking D6: several infl  am-
matory chemokines built to higher levels in 
the circulation and placenta; more macro-
phages and T lymphocytes invaded the 
placenta; and there was more fetal loss.
Fetal loss may occur after a deadly positive 
feedback between infl   ammation and blood 
clotting in the placenta. In the mice lacking D6, 
this can be prevented with an infusion of anti-
chemokine antibodies. A similar blocking 
approach may be possible in some humans 
who suffer from recurrent fetal loss, although it 
is not yet clear whether changes in D6 function 
are implicated in any of these individuals.
Reference: de la Torre, Y.M., et al. 2007. 
Proc. Natl. Acad. Sci. USA. doi:10.1073/
pnas.0607514104.
Pass the cycloheximide
W
orms with reduced protein production capacity live longer, 
according to Popi Syntichaki, Kostoula Troulinaki, and Nektarios 
Tavernarakis (IMBB, Foundation for Research and Technology, 
Heraklion, Greece). The reduction appears to save energy—energy that can 
be put to work in fi  xing life-threatening damage.
Protein translation rates decrease with age. Tavernarakis wondered if 
increased translation might increase turnover of damaged proteins and thus 
slow aging. But, he says, “what we found was the opposite.”
The group knocked down the levels of IFE-2, one of the fi  ve isoforms of the 
eIF4E translation initiation factor in worms. The development and eating 
patterns of the worms were normal, but they had an extended lifespan.
Other longevity-promoting pathways, such as the insulin and caloric 
restriction pathways, may modulate the eIF4E pathway (e.g., caloric 
restriction may reduce protein synthesis by down-regulating eIF4E). But 
ife-2 knockout was additive with mutation of these other pathways, 
suggesting that a simple linear relationship is unlikely.
Animals with less eIF4E had higher ATP levels and were more able to resist 
oxidative damage. “If we reduce the rate of protein synthesis we allow the cell 
to invest some extra energy in maintenance and repair functions,” says 
Tavernarakis. “By repairing damage the cells can now survive for longer.”
This benefi  t is only relevant in the soma. In the germline, by contrast, 
translation is already near a minimum and a further reduction in eIF4E 
activity was lethal. “The germline invests in repair and maintenance but not 
so much in building,” says Tavernarakis. “If we make our soma look a little 
more like our germline…then we might prolong the life of the soma.”
Reference: Syntichaki, P., et al. 2007. Nature. doi:10.1038/nature05603.
Smad2 (green) motors along 
microtubules (red). 
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D6 (black) protects placenta from invading chemokines.
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